Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 353.00
Ask: 379.00
Change: -3.00 (-0.83%)
Spread: 26.00 (7.365%)
Open: 361.00
High: 362.00
Low: 356.00
Prev. Close: 361.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funds Under Management - Trading Update

17 Jan 2017 07:00

RNS Number : 2882U
City of London Investment Group PLC
17 January 2017
 

RNS Number:

City of London Investment Group PLC

17 January 2017



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", the "Group" or the "Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 DECEMBER 2016,

TRADING UPDATE

 

City of London (LSE: CLIG) announces that total funds under management (FuM) at the Group's half year end on 31 December 2016 were US$4.1 billion (£3.3 billion). This compares with US$4.0 billion (£3.0 billion) at the Company's year-end on 30 June 2016.

 

This rise in FuM of 2.5% compares with a gain of 4.5% in the MSCI Emerging Markets TR Index (NDUEEGF) over the six month period to 31 December 2016. Investment performance in the Emerging closed-end fund (CEF) strategy over the short term has been challenging. Our country allocation in 2016 was weak and this was compounded by poor net asset value (NAV) performances of the underlying CEFs. Discounts remain wide across the sector, with the current size-weighted average discount (SWAD) at c. 13%-14%, indicating significant value in the strategy.

 

With regards to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings and has seen an increased interest in the diversification CEF strategies over the past 12 months. In total, the active pipeline is in excess of US$400 million, which includes opportunities that are spread across Emerging and Developed Markets, Global Tactical Asset Allocation, Tactical Income, and Frontier CEF strategies.

 

Operations

As of the end of December the monthly "run-rate" for operating profit, before profit-share of c.30%, is approximately £1.4 million per month based upon current FuM. The Group estimates the unaudited profit before taxation for the six months ended 31 December 2016 to be approximately £5.8 million, which compares with £3.6 million for the equivalent period to 31 December 2015.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2016 on 20 February 2017.

 

Template

Please see the attached graph which is based on the following assumptions and includes the estimated quarterly cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/2882U_-2017-1-16.pdf

 

Key assumptions:

 

(June 2016 comparatives in Italics)

· Starting point Current FuM (end December 2016)

· Net increase for the remainder of this financial year (straight-lined to June 2017):

- emerging market CEF strategy US$125m (US$250m over full year)

- non-emerging market CEF strategies US$125m (US$250m over the full year)

· Net increase in 2017/2018 (straight-lined to June 2018):

- emerging market CEF strategy US$125m

- non-emerging market CEF strategies US$125m

· Operating margin adjusted monthly for change in product mix and commission run-off

· Market growth: 0%

· Overheads for 2016/17: +10% compared to 2015/16 (+5%)

· Overheads for 2017/18: +11% compared to 2015/16

· EIP cost for 2016/17: 0.5% of operating profit

· EIP cost for 2017/18: 2% of operating profit

· Corporation tax based on an estimated average rate of 26% (26%)

· Exchange rate assumed to be £1/$1.23 for entire period (£1/US$1.35)

· Number of CLIG Shares in issue (26.9m) less those held by the ESOP Trust (1.7m) as at 31 December 2016 (26.9 m CLIG shares in issue less 1.9m ESOP Trust holding)

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUUCGUPMGQQ
Date   Source Headline
10th Aug 20072:40 pmRNSAIM Rule 26
11th Jun 20077:01 amRNSTrading Update
21st May 20078:50 amRNSResponse to Templeton
14th May 200712:22 pmRNSNotifiable Interest
12th Mar 20077:01 amRNSFunds Under Management
9th Mar 20071:57 pmRNSNotifiable Interest
28th Feb 20079:05 amRNSNotifiable Interest
20th Feb 20075:15 pmRNSNotifiable Interest
16th Feb 20074:11 pmRNSEquity Placing
29th Jan 20077:01 amRNSInterim Results
21st Dec 200612:28 pmRNSSale of Shareholding
14th Dec 20067:01 amRNSTotal Voting Rights
12th Dec 20067:01 amRNSFunds under management
6th Dec 200611:32 amRNSResponse to City of London
1st Dec 200612:00 pmRNSOpen Letter to Templeton
20th Nov 20061:09 pmRNSShare Purchase Agreement
13th Nov 200612:00 pmRNSDirector/PDMR Shareholding
30th Oct 200611:30 amRNSAGM Statement
18th Sep 20067:03 amRNSResources Investment Trust
18th Sep 20067:01 amRNSFinal Results
11th Sep 200610:09 amRNSNotice of Results
4th Jul 20064:13 pmRNSDirector/PDMR Shareholding
12th Jun 20067:01 amRNSPre Close Trading Update
30th May 20062:57 pmRNSDirectors Dealings
30th May 200612:36 pmRNSRe: Resources IT Plc
30th May 20067:01 amRNSDirectors Dealings
16th May 200610:26 amRNSSAR 3 - Resources Inv. Trust
4th May 200612:03 pmRNSSAR 5 - JP Morgan Russ
26th Apr 200610:52 amRNSSAR 5 - JP Morgan Russ
20th Apr 200611:51 amRNSSAR 5 - JPMorgan Russ
18th Apr 20061:07 pmRNSNotification of Interest
18th Apr 200612:14 pmRNSSAR 3 - Advance Developing
12th Apr 20067:00 amRNSPlacing and Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.